Loading...
Please wait, while we are loading the content...
Co-Infection of the Epstein-Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus.
| Content Provider | Europe PMC |
|---|---|
| Author | Böni, Michelle Rieble, Lisa Münz, Christian |
| Editor | He, Bin |
| Copyright Year | 2022 |
| Abstract | The two human tumor viruses, Epstein–Barr virus (EBV) and Kaposi sarcoma-associated herpesvirus (KSHV), have been mostly studied in isolation. Recent studies suggest that co-infection with both viruses as observed in one of their associated malignancies, namely primary effusion lymphoma (PEL), might also be required for KSHV persistence. In this review, we discuss how EBV and KSHV might support each other for persistence and lymphomagenesis. Moreover, we summarize what is known about their innate and adaptive immune control which both seem to be required to ensure asymptomatic persistent co-infection with these two human tumor viruses. A better understanding of this immune control might allow us to prepare for vaccination against EBV and KSHV in the future. |
| Journal | Viruses |
| Volume Number | 14 |
| PubMed Central reference number | PMC9782805 |
| Issue Number | 12 |
| PubMed reference number | 36560713 |
| e-ISSN | 19994915 |
| DOI | 10.3390/v14122709 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2022-12-02 |
| Access Restriction | Open |
| Rights License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). © 2022 by the authors. |
| Subject Keyword | natural killer cells cytotoxic lymphocytes T cells latent and lytic infection B cell lymphomas Kaposi sarcoma humanized mice |
| Content Type | Text |
| Resource Type | Article |
| Subject | Infectious Diseases Virology |